[HTML] springer.comFull View

[HTML][HTML] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

A Padilla-Galo, I Moya Carmona, P Ausín… - Respiratory …, 2023 - Springer
Abstract Background The ORBE II study aimed to describe the characteristics and clinical
outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab …
被引用次数：7 相关文章

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

A Padilla-Galo, IM Carmona, P Ausín… - Respiratory …, 2023 - pubmed.ncbi.nlm.nih.gov
Background The ORBE II study aimed to describe the characteristics and clinical outcomes
of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real …

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.

A Padilla-Galo, I Moya Carmona, P Ausín… - Respiratory …, 2023 - search.ebscohost.com
Abstract Background: The ORBE II study aimed to describe the characteristics and clinical
outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab …

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

A Padilla-Galo, IM Carmona, P Ausín… - Respiratory …, 2023 - search.proquest.com
Background The ORBE II study aimed to describe the characteristics and clinical outcomes
of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real …
[HTML] nih.gov

[HTML][HTML] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

A Padilla-Galo, IM Carmona, P Ausín… - Respiratory …, 2023 - ncbi.nlm.nih.gov
Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a
real-world setting: ORBE II study - PMC Back to Top Skip to main content NIH NLM Logo Access …
[HTML] biomedcentral.com

[HTML][HTML] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

A Padilla-Galo, I Moya Carmona… - Respiratory …, 2023 - respiratory-research.biomedcentral …
The ORBE II study aimed to describe the characteristics and clinical outcomes of adult
patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real-world …

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.

A Padilla-Galo, M Carmona, P Ausín… - Respiratory …, 2023 - europepmc.org
Background The ORBE II study aimed to describe the characteristics and clinical outcomes
of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real …

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.

A Padilla-Galo, M Carmona, P Ausín… - Respiratory …, 2023 - europepmc.org
Background The ORBE II study aimed to describe the characteristics and clinical outcomes
of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab in a real …
[PDF] biomedcentral.com

[PDF][PDF] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

A Padilla-Galo, IM Carmona, P Ausín… - 2023 - respiratory-research.biomedcentral …
Abstract Background The ORBE II study aimed to describe the characteristics and clinical
outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab …

Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study.

A Padilla-Galo, I Moya Carmona, P Ausín… - Respiratory …, 2023 - search.ebscohost.com
Abstract Background: The ORBE II study aimed to describe the characteristics and clinical
outcomes of adult patients with severe eosinophilic asthma (SEA) treated with benralizumab …